Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
Gerding WM, Tembrink M, Nilius-Eliliwi V, Mika T, Dimopoulos F, Ladigan-Badura S, Eckhardt M, Pohl M, Wünnenberg M, Farshi P, Reimer P, Schroers R, Nguyen HP, Vangala DB.
Gerding WM, et al. Among authors: dimopoulos f.
Int J Cancer. 2022 Jun 15;150(12):1998-2011. doi: 10.1002/ijc.33942. Epub 2022 Feb 7.
Int J Cancer. 2022.
PMID: 35064925
Free article.